Evidence map›Paper›PMID 28756246›Full record

ReviewToxicology2017

Inherited mitochondrial genomic instability and chemical exposures.

Sherine S L Chan

Open access · greenAbstract readReview
In one paragraph

Review in Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. PCR-Based Determination of Mitochondrial DNA Copy Number in Multiple Species.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  5. Article
  6. Mitochondrial Toxicity.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Review
  7. Mitochondrial diseases caused by mtDNA mutations: a mini-review.Therapeutics and clinical risk management · 2018
    Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sherine S L ChanDrug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, Charleston, SC 29425, United States; Neuroene Therapeutics, Mt. Pleasant, SC 29464, United States. Electronic address: chans@musc.edu.
Medical University of South Carolina · US

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cellsR01CA208514 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PAULOS, CHRYSTAL MARY · 2016 to 2020
$1.7M
Costimulatory mechanisms of antitumor Th17 cell immunityR01CA175061 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PAULOS, CHRYSTAL MARY · 2013 to 2017
$1.5M
The Mechanism of Mitochondrial DNA Proofreading in Human Health and DiseaseR00ES015555 · NIEHS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHAN, SHERINE S · 2009 to 2011
$747k
Adverse Actions of Stimulants on Embryonic Development and EnergeticsR21DA037706 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHAN, SHERINE S · 2014 to 2015
$409k
A model of Alpers SyndromeR21HD087645 · NICHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIM, SEOK-HYUNG · 2016 to 2017
$405k
Novel mechanism for the treatment of epilepsy: New Vitamin K analogs target energetics and have low toxicity due to excellent specificity and low dose requirements compared to current therapiesR41NS097047 · NINDS · NEUROENE THERAPEUTICS INC · PI CHAN, SHERINE S · 2016 to 2016
$225k
NCATS NIH HHS UL1 TR000062NCI NIH HHS R01 CA175061NCI NIH HHS R01 CA208514NICHD NIH HHS R21 HD087645NIDA NIH HHS R21 DA037706NIEHS NIH HHS R00 ES015555NINDS NIH HHS R41 NS097047
6 · The paper itself

Abstract

There are approximately 1500 proteins that are needed for mitochondrial structure and function, most of which are encoded in the nuclear genome (Calvo et al., 2006). Each mitochondrion has its own genome (mtDNA), which in humans encodes 13 polypeptides, 22 tRNAs and 2 rRNAs required for oxidative phosphorylation. The mitochondrial genome of humans and most vertebrates is approximately 16.5kbp, double-stranded, circular, with few non-coding bases. Thus, maintaining mtDNA stability, that is, the ability of the cell to maintain adequate levels of mtDNA template for oxidative phosphorylation is essential and can be impacted by the level of mtDNA mutation currently within the cell or mitochondrion, but also from errors made during normal mtDNA replication, defects in mitochondrial quality control mechanisms, and exacerbated by exposures to exogenous and/or endogenous genotoxic agents. In this review, we expand on the origins and consequences of mtDNA instability, the current state of research regarding the mechanisms by which mtDNA instability can be overcome by cellular and chemical interventions, and the future of research and treatments for mtDNA instability.

Indexed as

DNA DamageGenomic InstabilityAnimalsDNA, MitochondrialEcotoxicologyEnvironmental ExposureEnvironmental PollutantsGene-Environment InteractionHumansMitochondriaRisk AssessmentDNA, MitochondrialEnvironmental PollutantsDiseaseGene-environment interactionsMitochondriaMitochondrial DNATherapeuticsToxicity

Identifiers

PMID28756246
PMCPMC5681375
OpenAlexW2737412010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.